US Broker Ratings

Haemonetics Corporation (HAE) Stock Analysis: Uncovering a 23% Upside Potential Amidst Strong Buy Ratings

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative suite of hospital technologies...

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Uncovering a 20.78% Upside Potential in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector with its innovative approach to targeting protein growth factors. As a biopharmaceutical company,..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 40% Potential Upside Beckons Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector specializing in medical care facilities, presents an intriguing investment opportunity for those considering the..

Concentra Group Holdings (CON) Stock Analysis: Exploring a 40% Upside Potential

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector, specifically within the medical care facilities industry, presents an intriguing opportunity for investors..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 41% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, stands out with its robust portfolio of critical illness recovery hospitals, rehabilitation hospitals,..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 32% Potential Upside in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) is carving out a significant niche in the dynamic healthcare sector, specifically within the diagnostics and research industry. As a genomics..

Kiniksa Pharmaceuticals (KNSA) Investor Outlook: Eyeing a 43.68% Upside with Strong Buy Ratings

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is generating buzz among investors with its significant growth potential and strong analyst support. Operating in the healthcare sector, specifically within..

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a Potential 325% Upside

Investors eyeing the healthcare sector might find ImmunityBio, Inc. (NASDAQ: IBRX) an intriguing opportunity, particularly given the biotech company’s notable potential upside of 325.37%. Based in..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Biotech with 161% Potential Upside

Amicus Therapeutics, Inc. (FOLD), a key player in the biotechnology industry, is capturing investor attention with its impressive potential upside and innovative approach to treating rare..

Belite Bio, Inc (BLTE) Stock Analysis: Biotech Innovator with 38.66% Upside Potential

Belite Bio, Inc (BLTE) is making waves in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $1.99 billion, the company is..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 240% Upside Potential for Investors

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a key player in the biotechnology sector, stands out with its focus on developing treatments for rare and ultra-rare genetic diseases...

ICU Medical Inc. (ICUI) Stock Analysis: Exploring a Potential 53% Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a significant player in the healthcare sector, offers a diverse range of medical devices that are crucial for infusion therapy, vascular..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring an 84.81% Potential Upside for Investors

Ardent Health, Inc. (ARDT), a key player in the medical care facilities sector, offers an intriguing investment opportunity with a notable 84.81% potential upside based on..

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 60% Potential Upside with Strong Buy Ratings

Arcellx, Inc. (ACLX) stands out in the biotechnology sector, primarily due to its ambitious pursuit of cutting-edge immunotherapies targeting cancer and other severe diseases. Incorporated in..

Arrowhead Pharmaceuticals (ARWR): Unveiling a 199% Upside Potential with a Robust Product Pipeline

Investors keen on biotechnology firms might want to pay close attention to Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a company that stands out not only for its..

HUTCHMED (China) Limited (HCM): Investor Outlook Reveals 36% Potential Upside

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is making waves with its promising outlook and substantial potential upside. As a Hong..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 77.55% Potential Upside in the Healthcare Diagnostics Space

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare diagnostics and research industry, is currently garnering attention from the investment community. With a market capitalization..

Privia Health Group, Inc. (PRVA) Stock Analysis: A 50% Upside Potential with Strong Buy Ratings

Privia Health Group, Inc. (PRVA) presents itself as a compelling opportunity in the healthcare sector, particularly within the health information services industry. The company’s innovative approach..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Look at its Promising 32% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leader in the biotechnology sector, has been catching the eye of investors with its focus on rare and orphan diseases...

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unveiling a 46% Upside Potential in the Biotech Space

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning player in the biotech industry, is making waves with its promising pipeline of therapies targeting inflammatory diseases. Headquartered in Zug,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds